2JRE
 
 | | C60-1, a PDZ domain designed using statistical coupling analysis | | 分子名称: | C60-1 PDZ domain peptide | | 著者 | Larson, C, Stiffler, M, Li, P, Rosen, M, MacBeath, G, Ranganathan, R. | | 登録日 | 2007-06-25 | | 公開日 | 2008-07-01 | | 最終更新日 | 2023-12-20 | | 実験手法 | SOLUTION NMR | | 主引用文献 | C60-1, a PDZ domain designed using statistical coupling analysis
To be Published
|
|
5JFR
 | | Potent, Reversible MetAP2 Inhibitors via Fragment Based Drug Discovery | | 分子名称: | 1,2-ETHANEDIOL, 7-fluoro-4-(5-methyl-3H-imidazo[4,5-b]pyridin-6-yl)-2,4-dihydropyrazolo[4,3-b]indole, DIMETHYL SULFOXIDE, ... | | 著者 | Dougan, D.R, Lawson, J.D. | | 登録日 | 2016-04-19 | | 公開日 | 2016-05-25 | | 最終更新日 | 2016-06-15 | | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | | 主引用文献 | Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 2.
Bioorg.Med.Chem.Lett., 26, 2016
|
|
5JHU
 | | Potent, Reversible MetAP2 Inhibitors via FBDD | | 分子名称: | DIMETHYL SULFOXIDE, GLYCEROL, MANGANESE (II) ION, ... | | 著者 | Dougan, D.R. | | 登録日 | 2016-04-21 | | 公開日 | 2016-05-25 | | 最終更新日 | 2017-11-22 | | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | | 主引用文献 | Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 1.
Bioorg.Med.Chem.Lett., 26, 2016
|
|
5JI6
 | | Potent, Reversible MetAP2 Inhibitors via FBDD | | 分子名称: | 4-(3-methylpyridin-4-yl)-6-(trifluoromethyl)-1H-indazole, MANGANESE (II) ION, Methionine aminopeptidase 2, ... | | 著者 | Dougan, D.R, Lawson, J.D. | | 登録日 | 2016-04-21 | | 公開日 | 2016-05-25 | | 最終更新日 | 2017-11-22 | | 実験手法 | X-RAY DIFFRACTION (2.15 Å) | | 主引用文献 | Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 1.
Bioorg.Med.Chem.Lett., 26, 2016
|
|
